Encloni (CEO Lee Kyung-ho), a company specializing in machine vision-based appearance inspection, announced on the 17th that it will participate in the 'CIPM 2025 Autumn (China International Pharmaceutical Machinery Exposition)' held in Qingdao, China from October 16th to 18th and introduce its tablet and capsule appearance inspection equipment 'Planet EV'.
CIPM is China's leading international exhibition for pharmaceutical machinery. It serves as a platform for global pharmaceutical companies, equipment manufacturers, and testing solution providers to share the latest technologies and market trends. Through this exhibition, Encloni plans to expand its network of partnerships with partners in China and the Asian region.
The "Planet EV," exhibited this time, is an exterior inspection device utilizing high-speed, high-precision machine vision technology. It captures and analyzes tablets and capsules from a 360-degree angle, automatically identifying various defects, including minute foreign particles, damage, and discoloration. It supports stable quality control even in mass production environments, and its high-speed continuous line integration and modular structure enhance maintenance efficiency.
It also offers a multilingual user interface and supports optimization features tailored to local process requirements, making it suitable for the manufacturing environment of the Chinese and Asian markets.
An Enclony official said, “Through this CIPM participation, we will directly confirm the local demand for quality inspection automation and demonstrate Planet EV’s technological prowess on-site through product demonstrations,” adding, “We will expand our partnerships in Asian markets, including China, and expand our business in earnest based on trust in our technology.”
Meanwhile, Encloni is accelerating its entry into the European market by confirming its participation in Germany's 'CPHI Worldwide 2025' and is fully implementing a global market expansion strategy linking Asia and Europe.
- See more related articles
You must be logged in to post a comment.